Is $APUS pump-proof?

Apimeds Pharmaceuticals US, Inc.: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-09-07.

$APUS
Apimeds Pharmaceuticals US, Inc.
CLEAR RISK
17
/ 100 trap score
Price and crowd are quiet right now, but there's dilution machinery on file. Quiet isn't the same as clean; a rally here feeds the share printer.
Hype / crowding
13
Run-up / extension
5
Structural risk
38
!“Substantial doubt” (going-concern) language in a filing 25 days ago
🔒 3 more filings flagged on $APUS: see all of them free.
All 4 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-09-07 · not financial advice

The record on $APUS

first scored Jul 14: +164% since
30Jul 14
21Aug 24
25Aug 27
21Aug 28
17Aug 30
17Aug 31
21Sep 3
17Sep 7
Every score we publish is snapshotted the day it runs. Wins and misses stay on the record. Full ledger in the Friday email.
What these filings mean
What a going-concern warning means →Why penny stocks reverse-split →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.